Spinal muscular atrophy across the age spectrum

This activity is older than 12 months.

This case series has been developed with the assistance of Britton Zuccarelli MD (Salina Regional Health Center, KS), Vamshi Rao MD (Laurie Children’s Hospital of Chicago, IL), Anthony Geraci MD (Northwell Health, NY), and John Brandsema MD (Children’s Hospital of Philadelphia, PA).

The information presented is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of their professional license, experience, and knowledge of the individual patient.

For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events (AEs), please refer to the approved product labelling. Please note that products may have different product labelling according to geographical location. Full prescribing information is available from the US Food and Drug Administration (FDA) on Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/index.cfm).

All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental. This activity is intended only for healthcare professionals registered to practice in the USA. To proceed, please confirm that you are a healthcare professional practicing in the USA.

Please note that the clinical cases included in this series relate only to the natural history of SMA. Modern, targeted treatment discussions are beyond the scope of this particular series and have therefore not been included here.

Modules

• A 17-year-old female patient with falls and fatigue

• A hypotonic baby with failure to thrive

• A teenage boy with SMA, reaching adult age

• A 56-year-old woman with weak legs and a recent fall

• A floppy baby

• A 13-month-old not meeting his milestones

• A very sick newborn